Efeito da Olmesartana na resposta inflamatória em modelo de mucosite intestinal em ratos

Intestinal Mucositis is inflammation and/or ulceration of mucosa of the gastrointestinal tract caused by anticancer therapies. Histologically, villous atrophy, damage to enterocytes and infiltration of inflammatory cells. Methotrexate (MTX) is a compound that depletes dihydrofolate pools and is widely used in the treatment of leukemia and other malignancies. The aim of this study was to evaluate the effect of Olmesartan (OLM), an angiotensin II receptor antagonist, on an Intestinal Mucositis Model (IMM) induced by MTX in Wistar rats. IMM was induced via intraperitoneal (i.p.) administration of MTX (7 mg/kg) for three consecutive days. The animals were pretreated with oral OLM at 0.5, 1 or 5 mg/kg or with vehicle 30 min prior to exposure to MTX, for three days. Small intestinal (duodenum, jejunum and ileum) homogenates were assayed for levels of the IL-1β, IL-10 and TNF-α cytokines, malondialdehyde and myeloperoxidase activity. Additionally, immunohistochemical analyses of MMP-2, MMP-9, COX-2, RANK/RANKL and SOCS-1 and confocal microscopy analysis of SOCS-1 expression were performed. Treatment with MTX+OLM (5 mg/kg) resulted in a reduction of mucosal inflammatory infiltration, ulcerations, vasodilatation and hemorrhagic areas (p<0.05) as well as reduced concentrations of MPO (p<0.001) and the pro-inflammatory cytokines IL-1β and TNF-α (p<0.01), and increase antiinflammatory cytosine IL-10 (p,0.05). Additionally, the combined treatment reduced expression of MMP-2, MMP-9, COX-2, RANK and RANKL (p<0.05) and increased cytoplasmic expression of SOCS-1 (p<0.05). Our findings confirm the involvement of OLM in reducing the inflammatory response through increased immunosuppressive signaling in an IMM. We also suggest that the beneficial effect of Olmesartan treatment is specifically exerted during the damage through blocking inflammatory cytosines.

Farelo do bagaço de caju na restrição alimentar qualitativa para suínos em terminação

The objective of this study was to evaluate the effects of the use of cashew bagasse bran (CBB) as food ingredient in qualitative feed restriction programs on the carcass traits, meat quality, organs weight and intestinal morphometry of barrows and gilts. Twenty – four crossbred pigs were used (12 barrows and 12 gilts) with an average initial body weight of 57.93 ± 3.67 kg/LW. The experimental designs was in randomized blocks 3x2 factorial arrangement with three level (0%, 15% e 30% CBB), two genders (barrows and gilts) and four repetition. A total of twenty-four instalments. The treatments were composed of basal diet (BD) formulated with corn, soybean meal and commercial base mix for finishing pigs, being containing different levels of CBB. At the end of the trial period the animals were slaughtered for the evaluation of the meat quality, traits carcass, Absolute Weight (AW) and Relative Weight (RW) of the organs and morphometric study of small intestine fragment. The inclusion of (CBB) in the diets did not affect the traits carcass of gilts, but interfered in the traits carcass of the barrow positively, increasing the yield of meat into cold carcass and reducing the thickness of subcutaneous fat, without affecting the fatty acid profile. However, we observed increased weight of organs and partial volume of absortiva mucosa of gilts. In the comparison between sex was observed a greater liver weight (AW) and (RW), and surface density of absortiva mucosa of barrow. The use of CBB was considered as ingredient to be used in programs of qualitative feed restriction for finishing pigs.

Farelo do bagaço de caju na restrição alimentar qualitativa para suínos em terminação

The objective of this study was to evaluate the effects of the use of cashew bagasse bran (CBB) as food ingredient in qualitative feed restriction programs on the carcass traits, meat quality, organs weight and intestinal morphometry of barrows and gilts. Twenty – four crossbred pigs were used (12 barrows and 12 gilts) with an average initial body weight of 57.93 ± 3.67 kg/LW. The experimental designs was in randomized blocks 3x2 factorial arrangement with three level (0%, 15% e 30% CBB), two genders (barrows and gilts) and four repetition. A total of twenty-four instalments. The treatments were composed of basal diet (BD) formulated with corn, soybean meal and commercial base mix for finishing pigs, being containing different levels of CBB. At the end of the trial period the animals were slaughtered for the evaluation of the meat quality, traits carcass, Absolute Weight (AW) and Relative Weight (RW) of the organs and morphometric study of small intestine fragment. The inclusion of (CBB) in the diets did not affect the traits carcass of gilts, but interfered in the traits carcass of the barrow positively, increasing the yield of meat into cold carcass and reducing the thickness of subcutaneous fat, without affecting the fatty acid profile. However, we observed increased weight of organs and partial volume of absortiva mucosa of gilts. In the comparison between sex was observed a greater liver weight (AW) and (RW), and surface density of absortiva mucosa of barrow. The use of CBB was considered as ingredient to be used in programs of qualitative feed restriction for finishing pigs.

Exoenzimas em rações de frangos de corte

The study aimed to evaluate performance, relative weight of the small intestine, digestibility and deposition of minerals in the bone of broilers supplemented with enzymatic complex (carbohydrases and phytase) in sorghum-based diets or sorghum and millet. In the experiments based of sorghum and sorghum and millet were used 912 day-old male and female Hubbard Flex chicks (50:50) were distributed in a completely randomized design in a 2x2 factorial arrangement (Feed Control base Sorghum (Contcs); FeedReducedbase Sorghum (RedS); Feed Control base sorghum + Enzymatic Complex (Contcs + Enz);. Feed reduced base sorghum + Enzymatic Complex (RedS + Enz) in the study of feed basis of sorghum and millet the design was similar (Feed Control base sorghum + millet ( ContSM); Reduced feed based on Millet + Sorghum (RedSM); Feed Control based Sorghum + Millet + EnzimaticComplex (ContSM + Enz); Reduced Feed base Sorghum+ Millet + Enzimatic Complex (RedSM + Enz). At 35 and 42 days of age were determined performance data: feed intake (CR), body weight (BW), feed conversion (FC), viability (VIAB), relative weight of the small intestine and deposition of minerals in the bone. The digestibility was evaluated sorghum grain size (crushed and whole) with and without exoenzimatico complex. They used 32 birds, eight birds per treatment, in periods from 17 to 21 (initial) and 31 to 35 days of age (fattening). The exoenzimático complex used in feed favored the weight gain results, feed conversion and bone mineralization when compared to a control diet not added to enzymes, demonstrating its effect on non-starch polysaccharides and phosphorus phytic present as anti-nutritional factors in these diets, increasing the digestibility and supply of metabolizable energy, essential amino acids, methionine and lysine and calcium and phosphorus for bone formation. It is concluded that a safe strategy for inclusion in feed is based on the reduction of energy levels, essential amino acids, methionine and lysine and calcium and phosphorus in the expected result of the constant activity of the enzymes of this exoenzimático complex.

Haematological and biochemical blood study in baby alpaca with diarrhoea

The aim of this study was to determine the haematological value and biochemical blood in baby alpacas with enteric disorder. A total of 30 blood and serum samples were collected from alpacas of 1 month old with diarrhoea and 5 blood samples of clinically healthy baby alpacas (controls). The animals were from communities in the central Andes from Peru. About haematology were determined haematocrit, haemoglobin concentration, red blood count and white blood count that were not significantly different between control animals and animals with diarrhoea. Moreover, biochemical blood parameters as total protein, albumin and calcium decrease significantly (p<0.05). We conclude that our results could be considered as factors in the mortality of baby alpaca by infectious diarrhoea.

Biodistribution of the radiophamarceutical sodium pertechnetate (Na99mTcO4) after massive small bowel resection in rats

To evaluate the biodistribution of sodium pertecnetate (Na99mTcO4) in organs and tissues, the morphometry of remnant intestinal mucosa and ponderal evolution in rats subjected to massive resection of the small intestine. Methods: Twenty-one Wistar rats were randomly divided into three groups of 7 animals each. The short bowel (SB) group was subjected to massive resection of the small intestine; the control group (C) rats were not operated on, and soft intestinal handling was performed in sham rats. The animals were weighed weekly. On the 30th postoperative day, 0.l mL of Na99mTcO4, with mean activity of 0.66 MBq was injected intravenously into the orbital plexus. After 30 minutes, the rats were killed with an overdose of anesthetic, and fragments of the liver, spleen, pancreas, stomach, duodenum, small intestine, thyroid, lung, heart, kidney, bladder, muscle, femur and brain were harvested. The biopsies were washed with 0.9% NaCl.,The radioactivity was counted using Gama Counter WizardTM 1470, PerkinElmer. The percentage of radioactivity per gram of tissue (%ATI-g) was calculated. Biopsies of the remaining jejunum were analysed by HE staining to obtain mucosal thickness. Analysis of variance (ANOVA) and the Tukey test for multiple comparisons were used, considering p<0.05 as signifi cant. Results: There were no signifi cant differences in %ATI-g of the Na99mTcO4 in the organs of the groups studied (p>0.05). An increase in the weight of the SB rats was observed after the second postoperative week. The jejunal mucosal thickness of the SB rats was signifi cantly greater than that of C and sham rats (p<0.05). Conclusion: In rats with experimentally-produced short bowel syndrome, an adaptive response by the intestinal mucosa reduced weight loss. The biodistribution of Na99mTcO4 was not affected by massive intestinal resection, suggesting that short bowel syndrome is not the cause of misleading interpretation, if an examination using this radiopharmaceutical is indicated

Rendimiento de la canal y morfometría del tracto gastrointestinal de broilers suplementados con pared celular de levadura

Se realizó un experimento para evaluar el efecto de la suplementación de pollos de engorde con un derivado de paredes celulares de levadura Saccharomyces cerevisiae (PCL-glucano) de producción nacional sobre el rendimiento de la canal y la morfometría del tracto gastrointestinal. Se utilizaron 210 pollitos mixtos Cobb 500 de un día de edad, que fueron distribuidos en un diseño completamente al azar en tres tratamientos, con siete repeticiones y 10 aves por repetición. Los tratamientos evaluados fueron: T1: concentrado comercial (CC), T2: CC + 0.05% PCL-Glucano y T3: CC + 0.10% PCL-Glucano. A los 42 días de edad, los animales se pesaron y sacrificaron por dislocación de la articulación cráneo-cervical y se procedió a la extracción completa y cuidadosa del tracto gastrointestinal y la medición del peso absoluto y relativo de los órganos con respecto al peso corporal (expresados como % del peso vivo). Los resultados muestran que los mayores (p<0.05%) pesos absolutos y relativos de la molleja (67.9 g y 3.4%), hígado (76.9 g y 3.8%) e intestino delgado (88.4 g y 4.4%), a los 42 días de edad, se obtienen en los pollos alimentados con la dieta CC + 0.10% PCL-Glucano, lo que puede propiciar un mayor aprovechamiento de los nutrientes presentes en el alimento, contribuyendo al mejoramiento en los indicadores productivos de las aves (peso vivo, peso de la canal y rendimiento de la canal)

Is there still a role for intraoperative enteroscopy in patients with obscure gastrointestinal bleeding?

BACKGROUND: in 21st century, endoscopic study of the small intestine has undergone a revolution with capsule endoscopy and balloon-assisted enteroscopy. The difficulties and morbidity associated with intraoperative enteroscopy, the gold-standard in the 20th century, made this technique to be relegated to a second level. AIMS: evaluate the actual role and assess the diagnostic and therapeutic value of intraoperative enteroscopy in patients with obscure gastrointestinal bleeding. PATIENTS AND METHODS: we conducted a retrospective study of 19 patients (11 males; mean age: 66.5 ± 15.3 years) submitted to 21 IOE procedures for obscure GI bleeding. Capsule endoscopy and double balloon enteroscopy had been performed in 10 and 5 patients, respectively. RESULTS: with intraoperative enteroscopy a small bowel bleeding lesion was identified in 79% of patients and a gastrointestinal bleeding lesion in 94%. Small bowel findings included: angiodysplasia (n = 6), ulcers (n = 4), small bowel Dieulafoy´s lesion (n = 2), bleeding from anastomotic vessels (n = 1), multiple cavernous hemangiomas (n = 1) and bleeding ectopic jejunal varices (n = 1). Agreement between capsule endoscopy and intraoperative enteroscopy was 70%. Endoscopic and/or surgical treatment was used in 77.8% of the patients with a positive finding on intraoperative enteroscopy, with a rebleeding rate of 21.4% in a mean 21-month follow-up period. Procedure-related mortality and postoperative complications have been 5 and 21%, respectively. CONCLUSIONS: intraoperative enteroscopy remains a valuable tool in selected patients with obscure GI bleeding, achieving a high diagnostic yield and allowing an endoscopic and/or surgical treatment in most of them. However, as an invasive procedure with relevant mortality and morbidity, a precise indication for its use is indispensable.

Biodistribution of the radiophamarceutical sodium pertechnetate (Na99mTcO4) after massive small bowel resection in rats

To evaluate the biodistribution of sodium pertecnetate (Na99mTcO4) in organs and tissues, the morphometry of remnant intestinal mucosa and ponderal evolution in rats subjected to massive resection of the small intestine. Methods: Twenty-one Wistar rats were randomly divided into three groups of 7 animals each. The short bowel (SB) group was subjected to massive resection of the small intestine; the control group (C) rats were not operated on, and soft intestinal handling was performed in sham rats. The animals were weighed weekly. On the 30th postoperative day, 0.l mL of Na99mTcO4, with mean activity of 0.66 MBq was injected intravenously into the orbital plexus. After 30 minutes, the rats were killed with an overdose of anesthetic, and fragments of the liver, spleen, pancreas, stomach, duodenum, small intestine, thyroid, lung, heart, kidney, bladder, muscle, femur and brain were harvested. The biopsies were washed with 0.9% NaCl.,The radioactivity was counted using Gama Counter WizardTM 1470, PerkinElmer. The percentage of radioactivity per gram of tissue (%ATI-g) was calculated. Biopsies of the remaining jejunum were analysed by HE staining to obtain mucosal thickness. Analysis of variance (ANOVA) and the Tukey test for multiple comparisons were used, considering p<0.05 as signifi cant. Results: There were no signifi cant differences in %ATI-g of the Na99mTcO4 in the organs of the groups studied (p>0.05). An increase in the weight of the SB rats was observed after the second postoperative week. The jejunal mucosal thickness of the SB rats was signifi cantly greater than that of C and sham rats (p<0.05). Conclusion: In rats with experimentally-produced short bowel syndrome, an adaptive response by the intestinal mucosa reduced weight loss. The biodistribution of Na99mTcO4 was not affected by massive intestinal resection, suggesting that short bowel syndrome is not the cause of misleading interpretation, if an examination using this radiopharmaceutical is indicated

Qualidade de vida da pessoa portadora de ostomia na unidade local de saúde nordeste

Uma ostomia de eliminação intestinal resulta de um procedimento cirúrgico que consiste na ligação de uma parte do intestino delgado ou grosso, a um orifício externo na cavidade abdominal designado de estoma. O utente portador de uma ostomia de eliminação intestinal, devido à sua situação clínica, manifesta um misto de emoções resultante do enorme impacto físico e emocional devido à doença e ao tratamento. A sua própria vida vai desencadear alterações profundas no seu EU, nos estilos de vida, nas relações familiares e sociais, na sua imagem corporal e na autoestima (Pinto, 2012). Foi objetivo deste estudo analisar a perceção que a pessoa portadora de ostomia de eliminação intestinal, seguida na Unidade Local de Saúde Nordeste (ULSNE), tem sobre a sua qualidade de vida (QV). A investigação enquadra-se no domínio da investigação observacional, optando-se pela realização de um estudo descritivo, analítico e transversal, de abordagem quantitativa. Como instrumento de colheita de dados foi utilizado um formulário com questões relativas às características sociodemográficas, a escala de Graffar e a escala de avaliação da qualidade de vida do utente ostomizado. Aceitaram participar no estudo 105 utentes portadores de eliminação intestinal. O sexo predominante é o masculino (50,5%). A classe etária mais representativa é a dos 65 aos 92 anos (78,1%) e o estado civil predominante antes (67,6%) e depois (55,2%) da cirurgia é o de casado. Quanto à atividade laboral, o abandono do trabalho a tempo inteiro, devido à nova situação clínica, foi referido por 94,3% dos inquiridos. Em relação às habilitações académicas, 46,7% sabe ler e escrever, enquadrando-se na classe social média (57,1%). A consulta de estomaterapia na ULSNE ainda não está implementada, mas os inquiridos consideram que a sua implementação seria pertinente (93,3%), facilitando principalmente a adaptação à nova realidade (40%), a ultrapassar dificuldades (28,6%), a evitar complicações/resolver os problemas (9,5%). A média da QV dos participantes neste estudo é de 279,92, superior à média teórica da escala (215), indicando os inquiridos evidenciam um bom nível de qualidade de vida. O enfermeiro estomaterapeuta é o profissional que melhor pode proporcionar toda a informação e suportes necessários, que permitam ultrapassar os problemas e as limitações sentidas pelo ostomizado e pelas pessoas significativas na sua vida.

Actividad anti-giardia in vitro de los compuestos de foeniculum vulgare y citrus aurantifolia

Giardia lamblia es un protozoario parásito que habita el intestino delgado de humanos y otros vertebrados además de ser el agente responsable de la giardiasis. El fármaco de primera línea para tratar esta parasitosis es el metronidazol, el cual posee efectos adversos considerables, presenta potencial teratogénico y embriotóxico y está considerado como posible carcinógeno en humanos. Los productos naturales son una alternativa eficaz y con menos efectos secundarios para el tratamiento de la giardiasis. En el presente trabajo se determinó la Concentración Inhibitoria media (CI50) de los extractos hexánicos de Foeniculum vulgare y Citrus aurantifolia y algunos de sus constituyentes principales en contra de los trofozoítos de G. lamblia utilizando la técnica del microensayo. También se evaluó la citotoxicidad de los compuestos más activos sobre células Vero empleando el método de exclusión con azul de tripano. Contribuciones y Conclusiones: Los extractos hexánicos de F. vulgare (CI50 89.33 μg/ml) y C. aurantifolia (CI50 185.78 μg/ml) presentaron actividad anti-Giardia in vitro. Los compuestos puros más activos presentes en el extracto hexánico de F. vulgare son Trans,trans-2,4- undecadienal (CI50 72.11 μg/ml) , (+)-Canfeno (CI50 181.13 μg/ml), p-Anisaldehído (CI50 196.78 μg/ml) y (-)-Carvona (CI50 207.01 μg/ml). Mientras que los compuestos puros más activos presentes en el extracto hexánico de C. aurantifolia son Citral (CI50 58.44 μg/ml), Geraniol (CI50 229.01 μg/ml), 3-Metil-1,2-ciclopentanediona (CI50 207.01 μg/ml), 4-Hexen-3-ona (CI50 34.35 μg/ml) y (-)-Carvona (CI50 207.01 μg/ml). De todos ellos el 4-hexen-3ona es el compuesto puro más activo y con el mejor índice de selectividad (IS 19.6820). Ninguno de los compuestos fue tan activo como el metronidazol, sin embargo, ninguno fue tan citotóxico como este.

Phosphate uptake and phosphate transporter expression during immune cell proliferation in in vitro and ex vivo leukemic murine models

Dissertação de Mestrado, Ciências Biomédicas, Departamento de Medicina e Ciências Biomédicas, Universidade do Algarve, 2015

Diseño y evaluación in vitro de un sistema de liberación de gastrorretención de clorhidrato de metformina para diabetes tipo 2

Propósito y método del estudio: Diseñar y evaluar microcápsulas gastroflotantes de clorhidrato de metformina utilizando diferentes polímeros. Los sistemas de gastrorretención (SGR) son considerados como grandes oportunidades para fármacos que cuentan con una ventana de absorción muy estrecha en el tracto gastrointestinal. El poder lograr la disolución y liberación de estos fármacos antes de que lleguen a su sitio de absorción es la meta a seguir. El clorhidrato de metformina ampliamente utilizado en el tratamiento de diabetes mellitus, es absorbido en la parte superior de intestino delgado, por lo que es necesario que se encuentre disuelto antes llegar a su sitio de absorción, por dicha razón se decidió elaborar un sistema de gastrorretención flotante. Se elaboraron microcápsulas flotantes por el método de emulsión y evaporación de solvente utilizando el clorhidrato de metformina y los polímeros Eudragit RL 100, acetato de celulosa y acetobutirato de celulosa en diferentes proporciones. Contribuciones y Conclusiones: La variación en la velocidad de agitación, el porcentaje de los polímeros y demás excipientes son algunos factores que influyen en la formación de microcápsulas. Las microcápsulas obtenidas con clorhidrato de metformina se caracterizaron y se seleccionó la mejor formulación para evaluar y comparar su perfil de liberación con un producto comercial de liberación prologada. La elaboración de formas farmacéuticas gastroflotantes implica una constante búsqueda y recopilación exhaustiva de información así como ensayos de prueba y error con la formulación y el método para la generación de importantes avances y conocimientos útiles en el desarrollo de nuevas opciones de formas farmacéuticas de liberación prolongada.

Cardiopatias congênitas em um serviço de referência: evolução clínica e doenças associadas

FUNDAMENTO: Inúmeros fatores vêm contribuindo para a mudança do perfil do paciente com cardiopatia congênita (CC), incluindo o diagnóstico pré-natal e a disponibilidade de novos procedimentos terapêuticos. O conhecimento dessas mudanças é fundamental para um melhor atendimento. OBJETIVOS: Descrever o perfil dos pacientes com CC de um serviço de referência no Estado do Rio Grande do Sul, Brasil. MÉTODOS: Trata-se de um estudo transversal, com 684 pacientes portadores de CC, em um serviço de cardiologia pediátrica, de janeiro de 2007 a maio de 2008. Esses pacientes foram entrevistados (e/ou seus pais) e examinados (malformações congênitas, medidas antropométricas), além de terem seus prontuários revisados para mais detalhes sobre as cardiopatias, procedimentos e ecocardiografia. RESULTADOS: A idade dos pacientes variou de 16 dias a 66 anos, sendo 51,8% do sexo feminino, com 93,7% de brancos. A idade média determinada pelo diagnóstico foi de 15,8 ± 46,8 meses. As CC mais prevalentes foram a comunicação interventricular, a persistência do canal arterial e a Tetralogia de Fallot. Dos pacientes analisados, 59,1%, com idade média de 44,3 ± 71,2 meses, realizaram algum procedimento terapêutico; 30,4% tinham malformações congênitas extracardíacas; e 12 pacientes tinham síndrome genética comprovada. Quanto ao desenvolvimento, 46,6% tiveram atraso ponderoestatural e 13,7% atraso neuropsicomotor. Além disso, 18,4% apresentaram história familiar de cardiopatia congênita. CONCLUSÕES: O atraso neuropsicomotor e o baixo ganho ponderoestatural podem estar associados às CC. Estabelecer um perfil dos pacientes com CC atendidos em uma instituição de referência pode servir como base para o planejamento adequado do atendimento desta população.

Aspectos clínico-patológicos e controle da paratuberculose em rebanho bovino leiteiro

A paratuberculose ou doença de Johne é uma enterite granulomatosa causada por Mycobacterium avium subsp. paratuberculosis. Descrevem-se os aspectos epidemiológicos, clínico-patológicos e laboratoriais da paratuberculose em rebanho bovino leiteiro no município de Rio Claro, região Sul do Estado do Rio de Janeiro. No período de 2006 a 2009, oito vacas adultas da raça Girolanda apresentaram diarreia crônico-intermitente e perda progressiva de peso. À necropsia, observaram-se linfonodos mesentéricos aumentados de volume e úmidos ao corte, vasos linfáticos subserosos das alças intestinais proeminentes, serosa do intestino com aspecto anelado e cerebroide e a mucosa espessada, pregueada e com aspecto microgranular. À microscopia havia, desde o duodeno até o reto, inflamação granulomatosa difusa, marcada dilatação dos vasos linfáticos no ápice das vilosidades, linfangiectasia e linfangite granulomatosa na submucosa, muscular e serosa. A inflamação granulomatosa também foi vista nos linfonodos mesentéricos. A coloração de Ziehl-Neelsen revelou variável quantidade de bacilos álcool-ácido resistentes no interior de macrófagos, de células gigantes de Langhans e livres na mucosa e submucosa dos intestinos delgado e grosso e em linfonodos mesentéricos. Em alguns animais, a lâmina própria da mucosa, principalmente do jejuno e íleo exibia acentuada hipertrofia. Mycobacterium avium subsp. paratuberculosis foi isolado em cultivo bacteriano de Herrold com micobactina, a partir de amostras de fezes, de raspado de mucosa intestinal e de leite e identificado pela técnica de PCR IS900. Através da avaliação sorológica semestral, foram analisadas 298 vacas do mesmo rebanho a partir de três anos de idade, observou-se cerca de 40% de animais reagentes ao teste ELISA indireto no período estudado. O diagnóstico da paratuberculose foi baseado nos dados clínico-patológicos, na sorologia, no isolamento e identificação do agente através de cultivo bacteriano e PCR IS900. Após implementação de medidas de controle, tais como eliminação de animais doentes, abate seletivo dos animais soropositivos, separação dos bezerros ao nascer e utilização de banco de colostro, observou-se, nos três anos de estudo, diminuição da ocorrência de casos clínicos no rebanho, de seis casos por ano para cerca de um caso por ano.